Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers

INTRODUCTION: Endocrine therapy of breast cancer, which either deprives cancer tissue of estrogen or prevents estrogen pathway signaling, is the most common treatment after surgery and radiotherapy. We have previously shown for the estrogen-responsive MCF-7 cell line that exposure to tamoxifen, or d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Leung, Euphemia Y., Askarian-Amiri, Marjan E., Sarkar, Debina, Ferraro-Peyret, Carole, Joseph, Wayne R., Finlay, Graeme J., Baguley, Bruce C.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2017
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5591432/
https://ncbi.nlm.nih.gov/pubmed/28929082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2017.00184
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars